Hypera (OTCMKTS:HYPMY) Stock Crosses Below 50-Day Moving Average of $8.19
Hypera (OTCMKTS:HYPMY) Stock Crosses Below 50-Day Moving Average of $8.19
Hypera S.A. (OTCMKTS:HYPMY – Get Rating) shares crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $8.19 and traded as low as $8.03. Hypera shares last traded at $8.22, with a volume of 2,874 shares changing hands.
Hypera Trading Up 2.9 %
The firm has a market capitalization of $5.21 billion, a PE ratio of 19.69 and a beta of 0.80. The business has a 50 day moving average price of $8.19 and a 200-day moving average price of $7.84.
Hypera Company Profile
(Get Rating)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Recommended Stories
- Get a free copy of the StockNews.com research report on Hypera (HYPMY)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Let Paychex Stock Work Hard For You
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
Hypera S.A. (OTCMKTS:HYPMY – Get Rating) shares crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $8.19 and traded as low as $8.03. Hypera shares last traded at $8.22, with a volume of 2,874 shares changing hands.
Hypera S.A.(場外交易代碼：HYPMY-GET Rating)股價在週五的交易中跌破50日移動均線。該股的50日移動均線為8.19美元，交易價格低至8.03美元。Hypera股票最新報8.22美元，成交量為2,874股。
Hypera Trading Up 2.9 %
Hypera股價上漲2.9%
The firm has a market capitalization of $5.21 billion, a PE ratio of 19.69 and a beta of 0.80. The business has a 50 day moving average price of $8.19 and a 200-day moving average price of $7.84.
該公司市值為52.1億美元，市盈率為19.69倍，貝塔係數為0.80。該業務的50日移動均線價格為8.19美元，200日移動均線價格為7.84美元。
Hypera Company Profile
Hypera公司簡介
(Get Rating)
(獲取評級)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Hypera SA在巴西作為一家制藥公司運營。它提供的處方藥有Adacne、Addera、Apri、AmpliumG、請、賽萊他明、Celstone、Celstone Soluspana、Cizax、DECPRAX、衍生CMicro、Micro Drift、Dermol Fusid、Digedrat、雙丙胺、雙丙沙星、雙丙鬆、雙丙鬆、Emprol XR、Flow、Garasone、Halobx、Lipanon、Moon、Lydian、Macrodantin、MaxSulid、MilGamma、Mioflex-A、Nesina、Novotram、oximax、peridid、Perida混懸劑、Predsim、Pressaliv、Quadriderm、Rizi、Rizi、Softalm、acrotz、tinodin、umma和velunid品牌。
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on Hypera (HYPMY)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Let Paychex Stock Work Hard For You
- 免費獲取StockNews.com關於Hypera的研究報告(HYPMY)
- 電動汽車電池製造商Freyr將在全球大舉擴張
- MarketBeat：回顧一週9/26-9/30
- 這是買入美光科技的難忘時刻
- Keurig Dr Pepper與規模更大的競爭對手可口可樂(Coke&Pepsi)相比如何？
- 讓Paychex股票為您努力工作
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
接受Hypera Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Hypera和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧